(Q28237079)

Manfred Schubert-Zsilavecz

inferred from title

author

series ordinal

3

object named as

Manfred Schubert-Zsilavecz

0 references

Oliver Werz

series ordinal

2

object named as

Oliver Werz

0 references

author name string

Mona Abdel-Tawab

series ordinal

1

0 references

language of work or name

English

0 references

publication date

June 2011

0 references

published in

Clinical Pharmacokinetics

0 references

volume

50

0 references

issue

6

0 references

page(s)

349-69

0 references

cites work

Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Recent considerations in nonsteroidal anti-inflammatory drug gastropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in Switzerland.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Nonsteroidal anti-inflammatory drugs: a critical review on current concepts applied to reduce gastrointestinal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Boswellic acids: biological actions and molecular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Boswellic acids inhibit glioma growth: a new treatment option?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Boswellia: an evidence-based systematic review by the Natural Standard Research Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

A reversed phase high performance liquid chromatography method for the analysis of boswellic acids in Boswellia serrata

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Boswellic acids in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Metabolism of Boswellic Acids in Vitro and in Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Determination of boswellic acids in brain and plasma by high-performance liquid chromatography/tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Therapy of active Crohn disease with Boswellia serrata extract H 15

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Effects of gum resin of Boswellia serrata in patients with chronic colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Effects of Boswellia serrata in mouse models of chemically induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Incensole acetate: a novel neuroprotective agent isolated from Boswellia carterii.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Immunomodulatory activity of biopolymeric fraction BOS 2000 from Boswellia serrata

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

A test system for leukotriene synthesis inhibitors based on the in-vitro differentiation of the human leukemic cell lines HL-60 and Mono Mac 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Therapeutic options for 5-lipoxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Coupling of boswellic acid-induced Ca2+ mobilisation and MAPK activation to lipid metabolism and peroxide formation in human leucocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Activation of nuclear factor kappa B inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leucocyte adherence and inflammation in rat inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Arachidonic acid but not eicosapentaenoic acid (EPA) and oleic acid activates NF-kappaB and elevates ICAM-1 expression in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Glucocorticoids: do we know how they work?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Luminal cathepsin g and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Is H15 (resin extract of Boswellia serrata, "incense") a useful supplement to established drug therapy of chronic polyarthritis? Results of a double-blind pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee--a randomized double blind placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on rats with persistent inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on adjuvant-induced arthritis in lewis rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

A sensitive and relevant model for evaluating anti-inflammatory activity-papaya latex-induced rat paw inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Application of papaya latex-induced rat paw inflammation: model for evaluation of slowly acting antiarthritic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Effect of salai guggal ex-Boswellia serrata on cellular and humoral immune responses and leucocyte migration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Dietary support with Boswellia resin in canine inflammatory joint and spinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Epoxyeicosatrienoic acids, cell signaling and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on-line extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Macrophages and their products in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

mPGES-1 as a novel target for arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Prostaglandin E synthase in the pathophysiology of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

The lung as a privileged site for the beneficial actions of PGE2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Frankincense: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

The gastric ulcer protective effect of boswellic acids, a leukotriene inhibitor from Boswellia serrata, in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586800-000000000-00000

Concentration-dependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Anti-inflammatory actions of boswellic acids

1 reference

12 December 2020

Immunomodulatory activity of boswellic acids of Boswellia serrata Roxb

1 reference

12 December 2020

Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinases

1 reference

12 December 2020

Effects of Boswellia serrata gum resin in patients with ulcerative colitis

1 reference

12 December 2020

Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease

1 reference

12 December 2020

Development of a high-performance liquid chromatographic method for the determination of 11-keto-beta-boswellic acid in human plasma

1 reference

12 December 2020

Acetyl-11-keto-beta-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis

1 reference

12 December 2020

Mechanisms of acute and chronic intestinal inflammation induced by indomethacin

1 reference

12 December 2020

Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri

1 reference

12 December 2020

Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis

1 reference

12 December 2020

The efficacy of BAY y 1015 in dextran sulfate model of mouse colitis

1 reference

12 December 2020

Cardiovascular risks of COX inhibition: current perspectives

1 reference

12 December 2020

Boswellic acids stimulate arachidonic acid release and 12-lipoxygenase activity in human platelets independent of Ca2+ and differentially interact with platelet-type 12-lipoxygenase

1 reference

12 December 2020

Special extract of BOSWELLIA serrata (H 15) in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Pharmacokinetic study of 11-Keto beta-Boswellic acid

1 reference

12 December 2020

Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chromatography and photodiode array detection

1 reference

12 December 2020

Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid

1 reference

12 December 2020

Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis.

1 reference

12 December 2020

Selective 5-lipoxygenase inhibition in ulcerative colitis

1 reference

12 December 2020

Stimulation of leukotriene synthesis in intact polymorphonuclear cells by the 5-lipoxygenase inhibitor 3-oxo-tirucallic acid

1 reference

12 December 2020

Cathepsin G: the significance in rheumatoid arthritis as a monocyte chemoattractant

1 reference

12 December 2020

5-Lipoxygenase: a target for antiinflammatory drugs revisited

1 reference

12 December 2020

Microglia cyclooxygenase-2 activity in experimental gliomas: possible role in cerebral edema formation.

1 reference

12 December 2020

Anti-inflammatory activity of resins from some species of the plant family Burseraceae

1 reference

12 December 2020

Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro

1 reference

12 December 2020

Arachidonic acid metabolites: mediators of inflammation in asthma.

1 reference

12 December 2020

Inhibition by boswellic acids of human leukocyte elastase

1 reference

12 December 2020

Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study

1 reference

12 December 2020

Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent

1 reference

12 December 2020

Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study

1 reference

12 December 2020

Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1))

1 reference

12 December 2020

Salai Guggal - Boswellia serrata: from a herbal medicine to a non-redox inhibitor of leukotriene biosynthesis

1 reference

12 December 2020

A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg

1 reference

12 December 2020

Inhibition of Leukotriene B4Formation in Rat Peritoneal Neutrophils by an Ethanolic Extract of the Gum Resin Exudate ofBoswellia serrata

1 reference

12 December 2020

Anti-cathepsin G antibodies in the sera of patients with ulcerative colitis

1 reference

12 December 2020

Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase

1 reference

12 December 2020

Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy

1 reference

12 December 2020

Boswellic acids activate p42(MAPK) and p38 MAPK and stimulate Ca(2+) mobilization

1 reference

12 December 2020

Levels of Peptidoleukotriene E4 Are Elevated in Active Crohnʼs Disease

1 reference

12 December 2020

Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity

1 reference

12 December 2020